Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 3341–3360 of 17,529 recalls

April 25, 2022· SCA Pharmaceuticals

Recalled Item: Fentanyl 2mcg/ml and Bupivacaine 0.125% in 0.9% Sodium Chloride 100 mL bags

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 25, 2022· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Zonisamide Capsules

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
April 25, 2022· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Zonisamide Capsules USP

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
April 25, 2022· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Zonisamide Capsules

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
April 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 10 mg

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 20 mg

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 40 mg

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 21, 2022· McKesson Corporation dba McKesson Drug Company

Recalled Item: Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL)

The Issue: CGMP Deviations: all products within expiry are being

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 21, 2022· McKesson Corporation dba McKesson Drug Company

Recalled Item: Erythromycin Topical Gel USP

The Issue: CGMP Deviations: all products within expiry are being

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 21, 2022· McKesson Corporation dba McKesson Drug Company

Recalled Item: Halobetasol Propionate Ointment 0.05% Net Wt.

The Issue: CGMP Deviations: all products within expiry are being

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 21, 2022· McKesson Corporation dba McKesson Drug Company

Recalled Item: Lidocaine Prilocaine Cream USP

The Issue: CGMP Deviations: all products within expiry are being

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 21, 2022· McKesson Corporation dba McKesson Drug Company

Recalled Item: Betamethasone Dipropionate Ointment USP

The Issue: CGMP Deviations: all products within expiry are being

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 21, 2022· Torco Race Fuels

Recalled Item: TORCO RACING FUELS HAND SANITIZER

The Issue: CGMP Deviations: FDA analysis found product to contain

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 15, 2022· Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy

Recalled Item: Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension

The Issue: Subpotent drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
April 15, 2022· Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy

Recalled Item: Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension

The Issue: Subpotent drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
April 15, 2022· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium Tablets

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 15, 2022· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium Tablets

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 15, 2022· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium Tablets

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 15, 2022· Macleods Pharma Usa Inc

Recalled Item: Losartan Potassium & Hydrochlorothiazide Tablets

The Issue: CGMP Deviations- AZIDO Impurity levels observed to be

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 15, 2022· Akorn, Inc.

Recalled Item: Lidocaine Hydrochloride Oral Topical Solution

The Issue: Failed viscosity specification - product was below specificcation

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund